Suppr超能文献

对《重组人凝血因子IX聚乙二醇化修饰物:B型血友病综述》的更正

Correction to: Nonacog Beta Pegol: A Review in Haemophilia B.

作者信息

Syed Yahiya Y

机构信息

Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.

出版信息

Drugs. 2018 Jul;78(11):1169. doi: 10.1007/s40265-018-0951-1.

Abstract

The article Nonacog Beta Pegol: A Review in Haemophilia B, written by Yahiya Y. Syed, was originally published Online First without open access. After publication in volume 77, issue 18, pages 2003-2012 Novo Nordisk A/S requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Novo Nordisk A/S. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

摘要

由亚希亚·Y·赛义德撰写的《重组凝血因子IX聚乙二醇修饰物:B型血友病综述》一文最初以优先在线发表形式发布,无开放获取权限。在第77卷第18期第2003 - 2012页发表后,诺和诺德公司要求将该文章设为开放选择,以使文章成为开放获取出版物。出版后开放获取由诺和诺德公司资助。该文章随即根据知识共享署名 - 非商业性使用4.0国际许可协议(http://creativecommons.org/licenses/by-nc/4.0/)进行分发,该协议允许在任何媒介或格式下进行任何非商业性使用、复制、改编、分发和复制,只要您适当引用原始作者和来源、提供知识共享许可协议的链接并表明是否做了更改。

相似文献

10
Correction to: Ubrogepant: First Approval.更正:ubrogepant:首次批准。
Drugs. 2020 Apr;80(5):523. doi: 10.1007/s40265-020-01292-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验